Comparing dextrose prolotherapy with other substances in knee osteoarthritis pain relief: A systematic review

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA
Citação
CLINICS, v.77, article ID 100037, 11p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The objective of this study is to compare the effectiveness of dextrose-prolotherapy with other substances for pain relief in patients with primary knee osteoarthritis. The literature screening was done in January 2021 through Medline (PubMed), EMBASE, and Database of the National Institute of Health based on the following criteria: ran-domized clinical trials that subjected patients with primary knee osteoarthritis who underwent treatment with dextrose-prolotherapy and other substances for pain relief. Paired reviewers independently identified 3381 articles and included 8 trials that met the eligibility criteria. According to the findings of this review, participants that underwent dextrose-prolotherapy showed improvements between baseline and posterior assessments and when compared to saline injections, but when compared to other substances, the results were not clear. Although dextrose-prolotherapy is a useful treatment method by itself, it is still not possible to clearly affirm that it is supe-rior or inferior to its counterparts. There is an urgent need for further studies to bring more evidence to the field.
Palavras-chave
Prolotherapy, Dextrose, Knee, Osteoarthritis, Pain
Referências
  1. Bendich I, 2020, ARTHROSCOPY, V36, P1983, DOI 10.1016/j.arthro.2020.02.004
  2. Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93
  3. Cochrane Methods Screening and Diagnostic Tests, COCHRANE HDB SYSTEMA
  4. Copsey B, 2019, QUAL LIFE RES, V28, P335, DOI 10.1007/s11136-018-1978-1
  5. Cui AY, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100587
  6. Delgado DA, 2018, JAAOS GLOB RES REV, V2, DOI 10.5435/JAAOSGlobal-D-17-00088
  7. Fransen M, 1999, RHEUMATOLOGY, V38, P807, DOI 10.1093/rheumatology/38.9.807
  8. Fu XN, 2020, AM J TRANSL RES, V12, P6464
  9. HACKETT G S, 1960, Postgrad Med, V27, P214
  10. Hosseini B, 2019, OPEN ACCESS RHEUMATO, V11, P269, DOI 10.2147/OARRR.S215576
  11. Arias-Vazquez PI, 2019, ADV RHEUMATOL, V59, DOI 10.1186/s42358-019-0083-7
  12. Jensen KT, 2008, AM J SPORT MED, V36, P1347, DOI 10.1177/0363546508314431
  13. Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412
  14. Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223
  15. Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4
  16. Pelfort X, 2015, ORTHOP TRAUMATOL-SUR, V101, P559, DOI 10.1016/j.otsr.2015.03.016
  17. Pishgahi A, 2020, IRAN J ALLERGY ASTHM, V19, P243, DOI 10.18502/ijaai.v19i3.3452
  18. Rabago D, 2013, ANN FAM MED, V11, P229, DOI 10.1370/afm.1504
  19. Rahimzadeh P, 2018, CLIN INTERV AGING, V13, P73, DOI 10.2147/CIA.S147757
  20. Rahimzadeh P, 2014, J RES MED SCI, V19, P696
  21. REJESKI WJ, 1995, J RHEUMATOL, V22, P1124
  22. Rezasoltani Z, 2020, INT J REHABIL RES, V43, P219, DOI 10.1097/MRR.0000000000000411
  23. Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64
  24. Sert AT, 2020, J ALTERN COMPLEM MED, V26, P409, DOI 10.1089/acm.2019.0335
  25. Sit RWS, 2020, ANN FAM MED, V18, P235, DOI 10.1370/afm.2520
  26. [陶欢 Tao Huan], 2018, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V18, P101
  27. The Osteoarthritis Action Alliance (OAAA), COST OST OST ACT ALL
  28. University of Illinois at Chicago's library of the health sciences at Peoria, WHAT IS PICO MOD
  29. Vaishya Raju, 2016, J Clin Orthop Trauma, V7, P170, DOI 10.1016/j.jcot.2016.05.005
  30. Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008